0001415889-24-017241.txt : 20240617 0001415889-24-017241.hdr.sgml : 20240617 20240617170023 ACCESSION NUMBER: 0001415889-24-017241 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240613 FILED AS OF DATE: 20240617 DATE AS OF CHANGE: 20240617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: William Arsani CENTRAL INDEX KEY: 0001848372 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40288 FILM NUMBER: 241049098 MAIL ADDRESS: STREET 1: C/O DESIGN THERAPEUTICS, INC. STREET 2: 6005 HIDDEN VALLEY ROAD, SUITE 110 CITY: CARLSBAD STATE: CA ZIP: 92011 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Design Therapeutics, Inc. CENTRAL INDEX KEY: 0001807120 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 823929248 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6005 HIDDEN VALLEY ROAD STREET 2: SUITE 110 CITY: CARLSBAD STATE: CA ZIP: 92011 BUSINESS PHONE: 858-293-4900 MAIL ADDRESS: STREET 1: 6005 HIDDEN VALLEY ROAD STREET 2: SUITE 110 CITY: CARLSBAD STATE: CA ZIP: 92011 4 1 form4-06172024_050620.xml X0508 4 2024-06-13 0001807120 Design Therapeutics, Inc. DSGN 0001848372 William Arsani C/O DESIGN THERAPEUTICS, INC. 6005 HIDDEN VALLEY ROAD, SUITE 110 CARLSBAD CA 92011 true false false false 0 Stock Option (right to buy) 3.82 2024-06-13 4 A 0 19000 0 A 2034-06-12 Common Stock 19000 19000 D The shares subject to the option vest in equal monthly installments over 12 months following June 13, 2024 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders. /s/ Mustapha Parekh, Attorney-in-Fact 2024-06-17